Selected research
Market Analysis & Forecast
Global Drugs for PNH Market Analysis and Forecast 2026-2032
Market perspective
The global Drugs for PNH market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Drugs for PNH is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Drugs for PNH is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Drugs for PNH is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Drugs for PNH is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Drugs for PNH include Alexion Pharmaceuticals, Amgen, Apellis Pharmaceuticals, Roche, Novartis and Samsung Bioepis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Drugs for PNH, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Drugs for PNH, also provides the sales of main regions and countries. Of the upcoming market potential for Drugs for PNH, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drugs for PNH sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drugs for PNH market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Drugs for PNH sales, projected growth trends, production technology, application and end-user industry.
Drugs for PNH Segment by Company
Alexion Pharmaceuticals
Amgen
Apellis Pharmaceuticals
Roche
Novartis
Samsung Bioepis
Drugs for PNH Segment by Type
Complement Inhibitors
Others
Drugs for PNH Segment by Application
Hospital
Clinic
Other
Drugs for PNH Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for PNH market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for PNH and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for PNH.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Drugs for PNH in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Drugs for PNH manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for PNH sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Complement Inhibitors
- Others
Applications
- Hospital
- Clinic
- Other
Companies covered
- Alexion Pharmaceuticals
- Amgen
- Apellis Pharmaceuticals
- Roche
- Novartis
- Samsung Bioepis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Drugs for PNH Market by Type
- 1.2.1 Global Drugs for PNH Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Complement Inhibitors
- 1.2.3 Others
- 1.3 Drugs for PNH Market by Application
- 1.3.1 Global Drugs for PNH Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Drugs for PNH Market Dynamics
- 2.1 Drugs for PNH Industry Trends
- 2.2 Drugs for PNH Industry Drivers
- 2.3 Drugs for PNH Industry Opportunities and Challenges
- 2.4 Drugs for PNH Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Drugs for PNH Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Drugs for PNH Revenue by Region
- 3.2.1 Global Drugs for PNH Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Drugs for PNH Revenue by Region (2021-2026)
- 3.2.3 Global Drugs for PNH Revenue by Region (2027-2032)
- 3.2.4 Global Drugs for PNH Revenue Market Share by Region (2021-2032)
- 3.3 Global Drugs for PNH Sales Estimates and Forecasts 2021-2032
- 3.4 Global Drugs for PNH Sales by Region
- 3.4.1 Global Drugs for PNH Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Drugs for PNH Sales by Region (2021-2026)
- 3.4.3 Global Drugs for PNH Sales by Region (2027-2032)
- 3.4.4 Global Drugs for PNH Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Drugs for PNH Revenue by Manufacturers
- 4.1.1 Global Drugs for PNH Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Drugs for PNH Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Drugs for PNH Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Drugs for PNH Sales by Manufacturers
- 4.2.1 Global Drugs for PNH Sales by Manufacturers (2021-2026)
- 4.2.2 Global Drugs for PNH Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Drugs for PNH Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Drugs for PNH Sales Price by Manufacturers (2021-2026)
- 4.4 Global Drugs for PNH Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Drugs for PNH Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Drugs for PNH Manufacturers, Product Type & Application
- 4.7 Global Drugs for PNH Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Drugs for PNH Market CR5 and HHI
- 4.8.2 2025 Drugs for PNH Tier 1, Tier 2, and Tier 3
5 Drugs for PNH Market by Type
- 5.1 Global Drugs for PNH Revenue by Type
- 5.1.1 Global Drugs for PNH Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Drugs for PNH Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Drugs for PNH Revenue Market Share by Type (2021-2032)
- 5.2 Global Drugs for PNH Sales by Type
- 5.2.1 Global Drugs for PNH Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Drugs for PNH Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Drugs for PNH Sales Market Share by Type (2021-2032)
- 5.3 Global Drugs for PNH Price by Type
6 Drugs for PNH Market by Application
- 6.1 Global Drugs for PNH Revenue by Application
- 6.1.1 Global Drugs for PNH Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Drugs for PNH Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Drugs for PNH Revenue Market Share by Application (2021-2032)
- 6.2 Global Drugs for PNH Sales by Application
- 6.2.1 Global Drugs for PNH Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Drugs for PNH Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Drugs for PNH Sales Market Share by Application (2021-2032)
- 6.3 Global Drugs for PNH Price by Application
7 Company Profiles
- 7.1 Alexion Pharmaceuticals
- 7.1.1 Alexion Pharmaceuticals Company Information
- 7.1.2 Alexion Pharmaceuticals Business Overview
- 7.1.3 Alexion Pharmaceuticals Drugs for PNH Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Alexion Pharmaceuticals Drugs for PNH Product Portfolio
- 7.1.5 Alexion Pharmaceuticals Recent Developments
- 7.2 Amgen
- 7.2.1 Amgen Company Information
- 7.2.2 Amgen Business Overview
- 7.2.3 Amgen Drugs for PNH Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Amgen Drugs for PNH Product Portfolio
- 7.2.5 Amgen Recent Developments
- 7.3 Apellis Pharmaceuticals
- 7.3.1 Apellis Pharmaceuticals Company Information
- 7.3.2 Apellis Pharmaceuticals Business Overview
- 7.3.3 Apellis Pharmaceuticals Drugs for PNH Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Apellis Pharmaceuticals Drugs for PNH Product Portfolio
- 7.3.5 Apellis Pharmaceuticals Recent Developments
- 7.4 Roche
- 7.4.1 Roche Company Information
- 7.4.2 Roche Business Overview
- 7.4.3 Roche Drugs for PNH Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Roche Drugs for PNH Product Portfolio
- 7.4.5 Roche Recent Developments
- 7.5 Novartis
- 7.5.1 Novartis Company Information
- 7.5.2 Novartis Business Overview
- 7.5.3 Novartis Drugs for PNH Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Novartis Drugs for PNH Product Portfolio
- 7.5.5 Novartis Recent Developments
- 7.6 Samsung Bioepis
- 7.6.1 Samsung Bioepis Company Information
- 7.6.2 Samsung Bioepis Business Overview
- 7.6.3 Samsung Bioepis Drugs for PNH Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Samsung Bioepis Drugs for PNH Product Portfolio
- 7.6.5 Samsung Bioepis Recent Developments
8 North America
- 8.1 North America Drugs for PNH Market Size by Type
- 8.1.1 North America Drugs for PNH Revenue by Type (2021-2032)
- 8.1.2 North America Drugs for PNH Sales by Type (2021-2032)
- 8.1.3 North America Drugs for PNH Price by Type (2021-2032)
- 8.2 North America Drugs for PNH Market Size by Application
- 8.2.1 North America Drugs for PNH Revenue by Application (2021-2032)
- 8.2.2 North America Drugs for PNH Sales by Application (2021-2032)
- 8.2.3 North America Drugs for PNH Price by Application (2021-2032)
- 8.3 North America Drugs for PNH Market Size by Country
- 8.3.1 North America Drugs for PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Drugs for PNH Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Drugs for PNH Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Drugs for PNH Market Size by Type
- 9.1.1 Europe Drugs for PNH Revenue by Type (2021-2032)
- 9.1.2 Europe Drugs for PNH Sales by Type (2021-2032)
- 9.1.3 Europe Drugs for PNH Price by Type (2021-2032)
- 9.2 Europe Drugs for PNH Market Size by Application
- 9.2.1 Europe Drugs for PNH Revenue by Application (2021-2032)
- 9.2.2 Europe Drugs for PNH Sales by Application (2021-2032)
- 9.2.3 Europe Drugs for PNH Price by Application (2021-2032)
- 9.3 Europe Drugs for PNH Market Size by Country
- 9.3.1 Europe Drugs for PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Drugs for PNH Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Drugs for PNH Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Drugs for PNH Market Size by Type
- 10.1.1 China Drugs for PNH Revenue by Type (2021-2032)
- 10.1.2 China Drugs for PNH Sales by Type (2021-2032)
- 10.1.3 China Drugs for PNH Price by Type (2021-2032)
- 10.2 China Drugs for PNH Market Size by Application
- 10.2.1 China Drugs for PNH Revenue by Application (2021-2032)
- 10.2.2 China Drugs for PNH Sales by Application (2021-2032)
- 10.2.3 China Drugs for PNH Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Drugs for PNH Market Size by Type
- 11.1.1 Asia Drugs for PNH Revenue by Type (2021-2032)
- 11.1.2 Asia Drugs for PNH Sales by Type (2021-2032)
- 11.1.3 Asia Drugs for PNH Price by Type (2021-2032)
- 11.2 Asia Drugs for PNH Market Size by Application
- 11.2.1 Asia Drugs for PNH Revenue by Application (2021-2032)
- 11.2.2 Asia Drugs for PNH Sales by Application (2021-2032)
- 11.2.3 Asia Drugs for PNH Price by Application (2021-2032)
- 11.3 Asia Drugs for PNH Market Size by Country
- 11.3.1 Asia Drugs for PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Drugs for PNH Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Drugs for PNH Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Drugs for PNH Market Size by Type
- 12.1.1 SAMEA Drugs for PNH Revenue by Type (2021-2032)
- 12.1.2 SAMEA Drugs for PNH Sales by Type (2021-2032)
- 12.1.3 SAMEA Drugs for PNH Price by Type (2021-2032)
- 12.2 SAMEA Drugs for PNH Market Size by Application
- 12.2.1 SAMEA Drugs for PNH Revenue by Application (2021-2032)
- 12.2.2 SAMEA Drugs for PNH Sales by Application (2021-2032)
- 12.2.3 SAMEA Drugs for PNH Price by Application (2021-2032)
- 12.3 SAMEA Drugs for PNH Market Size by Country
- 12.3.1 SAMEA Drugs for PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Drugs for PNH Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Drugs for PNH Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Drugs for PNH Value Chain Analysis
- 13.1.1 Drugs for PNH Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Drugs for PNH Production Mode & Process
- 13.2 Drugs for PNH Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Drugs for PNH Distributors
- 13.2.3 Drugs for PNH Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst